Hardman & Co Research

HARDMAN & CO RESEARCH

30/06/2022 08:15

Hardman & Co Research: International Biotechnology Trust (IBT) - M&A activity on the rise

Voir tous les communiqués de Hardman & Co Research

HARDMAN & CO RESEARCH

23/06/2022 16:40

Hardman & Co Research: Q&A on ICG Enterprise Trust: How ICGT gave investors market-beating returns

Voir tous les communiqués de Hardman & Co Research

HARDMAN & CO RESEARCH

16/06/2022 10:15

Hardman & Co Research: Q&A on Chesnara Plc (CSN): Good performance analysed

Voir tous les communiqués de Hardman & Co Research

HARDMAN & CO RESEARCH

14/06/2022 11:30

Hardman & Co Research: Q&A on Real Estate Credit Investments: RECI resilient against inflation and interest rate increases

Voir tous les communiqués de Hardman & Co Research

HARDMAN & CO RESEARCH

10/06/2022 12:05

Hardman & Co Research: Q&A on Oakley Capital Investments: Impressive market and peer-beating 19% NAV CAGR growth 2017-21

Voir tous les communiqués de Hardman & Co Research

HARDMAN & CO RESEARCH

10/06/2022 02:00

Hardman & Co Life Sciences Research: Long-term pharmaceutical industry cost and EBIT analysis

Voir tous les communiqués de Hardman & Co Research

HARDMAN & CO RESEARCH

07/06/2022 17:50

Hardman & Co Research: ICG Enterprise Trust (ICGT) - FY’22: you couldn’t ask for more

Voir tous les communiqués de Hardman & Co Research

HARDMAN & CO RESEARCH

07/06/2022 08:30

Hardman & Co Life Sciences Research: Long-term cost and EBIT analysis of the pharmaceutical industry

Voir tous les communiqués de Hardman & Co Research

HARDMAN & CO RESEARCH

24/05/2022 08:00

Hardman & Co Research : Chesnara plc (CSN): Market benefits overwhelm operational challenges

Voir tous les communiqués de Hardman & Co Research

HARDMAN & CO RESEARCH

20/05/2022 17:02

Hardman & Co Research : Real Estate Credit Investments (RECI) - New faces, same resilience

Voir tous les communiqués de Hardman & Co Research

1
2
3
4
5
6
7
8
9
10
»